Clinical Trial Update: Inolitazone Dihydrochloride and Paclitaxel in Treating Patients With Advanced Anaplastic Thyroid Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial results for the combination of inolitazone dihydrochloride and paclitaxel in advanced anaplastic thyroid cancer; the update reports safety and eff…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anaplastic Thyroid Cancer
• Thyroid Cancer

Drugs mentioned

• Inolitazone Dihydrochloride (Inolitazone dihydrochloride)
• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: Alliance for Clinical Trials in Oncology | Conditions: Anaplastic Thyroid Cancer, Recurrent Thyroid Cancer | Phase 2 | Status: COMPLETED | Results posted: 2019-12-27